nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADA—pleura—esophageal cancer	0.162	0.401	CbGeAlD
Adenosine—DPP4—exocrine gland—esophageal cancer	0.0245	0.0606	CbGeAlD
Adenosine—SLC28A3—trachea—esophageal cancer	0.0182	0.0452	CbGeAlD
Adenosine—Apprehension—Cisplatin—esophageal cancer	0.0165	0.0878	CcSEcCtD
Adenosine—SLC28A3—digestive system—esophageal cancer	0.0157	0.0389	CbGeAlD
Adenosine—ADORA2B—bronchus—esophageal cancer	0.0145	0.0359	CbGeAlD
Adenosine—Ear discomfort—Capecitabine—esophageal cancer	0.0142	0.0756	CcSEcCtD
Adenosine—ADORA2B—smooth muscle tissue—esophageal cancer	0.0142	0.0351	CbGeAlD
Adenosine—SLC28A3—lung—esophageal cancer	0.0131	0.0325	CbGeAlD
Adenosine—ADORA2B—trachea—esophageal cancer	0.013	0.0322	CbGeAlD
Adenosine—ADK—bronchus—esophageal cancer	0.0108	0.0268	CbGeAlD
Adenosine—DPP4—epithelium—esophageal cancer	0.0107	0.0264	CbGeAlD
Adenosine—ADK—smooth muscle tissue—esophageal cancer	0.0106	0.0262	CbGeAlD
Adenosine—DPP4—smooth muscle tissue—esophageal cancer	0.0103	0.0254	CbGeAlD
Adenosine—ADA—digestive system—esophageal cancer	0.0102	0.0253	CbGeAlD
Adenosine—ADK—trachea—esophageal cancer	0.00971	0.0241	CbGeAlD
Adenosine—ADORA2B—lung—esophageal cancer	0.00934	0.0231	CbGeAlD
Adenosine—ADA—lung—esophageal cancer	0.00854	0.0212	CbGeAlD
Adenosine—DPP4—digestive system—esophageal cancer	0.0081	0.0201	CbGeAlD
Adenosine—Coronary artery disease—Cisplatin—esophageal cancer	0.00802	0.0426	CcSEcCtD
Adenosine—ADK—lung—esophageal cancer	0.00698	0.0173	CbGeAlD
Adenosine—DPP4—lung—esophageal cancer	0.00677	0.0168	CbGeAlD
Adenosine—ADORA1—lung—esophageal cancer	0.00671	0.0166	CbGeAlD
Adenosine—ADA—lymph node—esophageal cancer	0.00584	0.0145	CbGeAlD
Adenosine—Sinus tachycardia—Capecitabine—esophageal cancer	0.0058	0.0308	CcSEcCtD
Adenosine—Taste metallic—Methotrexate—esophageal cancer	0.00547	0.029	CcSEcCtD
Adenosine—ADK—lymph node—esophageal cancer	0.00477	0.0118	CbGeAlD
Adenosine—DPP4—lymph node—esophageal cancer	0.00463	0.0115	CbGeAlD
Adenosine—ADORA1—lymph node—esophageal cancer	0.00459	0.0114	CbGeAlD
Adenosine—Adenosine monophosphate—PDE4D—esophageal cancer	0.00434	0.313	CrCbGaD
Adenosine—Adenosine triphosphate—ABL1—esophageal cancer	0.00363	0.262	CrCbGaD
Adenosine—Tenofovir—ABCC2—esophageal cancer	0.00338	0.244	CrCbGaD
Adenosine—Torsade de pointes—Capecitabine—esophageal cancer	0.00333	0.0177	CcSEcCtD
Adenosine—Pain—Carboplatin—esophageal cancer	0.0033	0.0175	CcSEcCtD
Adenosine—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00305	0.0162	CcSEcCtD
Adenosine—Tingling sensation—Capecitabine—esophageal cancer	0.00291	0.0154	CcSEcCtD
Adenosine—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00291	0.0154	CcSEcCtD
Adenosine—Extrasystoles—Capecitabine—esophageal cancer	0.00278	0.0147	CcSEcCtD
Adenosine—Chest discomfort—Capecitabine—esophageal cancer	0.00264	0.014	CcSEcCtD
Adenosine—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00259	0.0137	CcSEcCtD
Adenosine—Nasal congestion—Cisplatin—esophageal cancer	0.00253	0.0134	CcSEcCtD
Adenosine—Burning sensation—Methotrexate—esophageal cancer	0.00251	0.0133	CcSEcCtD
Adenosine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00235	0.0125	CcSEcCtD
Adenosine—Blood pressure increased—Capecitabine—esophageal cancer	0.00234	0.0124	CcSEcCtD
Adenosine—Injection site reaction—Capecitabine—esophageal cancer	0.00232	0.0123	CcSEcCtD
Adenosine—Apnoea—Methotrexate—esophageal cancer	0.00205	0.0109	CcSEcCtD
Adenosine—Abdominal discomfort—Cisplatin—esophageal cancer	0.00191	0.0101	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCC2—esophageal cancer	0.00182	0.132	CrCbGaD
Adenosine—Atrial fibrillation—Capecitabine—esophageal cancer	0.00179	0.0095	CcSEcCtD
Adenosine—Respiratory failure—Methotrexate—esophageal cancer	0.00177	0.0094	CcSEcCtD
Adenosine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00175	0.00928	CcSEcCtD
Adenosine—Myocardial infarction—Cisplatin—esophageal cancer	0.00174	0.00923	CcSEcCtD
Adenosine—Cardiac failure—Capecitabine—esophageal cancer	0.00174	0.00923	CcSEcCtD
Adenosine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00173	0.00919	CcSEcCtD
Adenosine—Bradycardia—Cisplatin—esophageal cancer	0.00162	0.0086	CcSEcCtD
Adenosine—Cardiac arrest—Capecitabine—esophageal cancer	0.00161	0.00856	CcSEcCtD
Adenosine—Mood swings—Capecitabine—esophageal cancer	0.00161	0.00853	CcSEcCtD
Adenosine—Tinnitus—Cisplatin—esophageal cancer	0.00148	0.00788	CcSEcCtD
Adenosine—Flushing—Cisplatin—esophageal cancer	0.00148	0.00784	CcSEcCtD
Adenosine—Cardiac disorder—Cisplatin—esophageal cancer	0.00148	0.00784	CcSEcCtD
Adenosine—Bronchospasm—Capecitabine—esophageal cancer	0.00144	0.00765	CcSEcCtD
Adenosine—Mediastinal disorder—Cisplatin—esophageal cancer	0.00144	0.00762	CcSEcCtD
Adenosine—Arrhythmia—Cisplatin—esophageal cancer	0.00142	0.00755	CcSEcCtD
Adenosine—Abdominal discomfort—Capecitabine—esophageal cancer	0.00141	0.00746	CcSEcCtD
Adenosine—Vision blurred—Cisplatin—esophageal cancer	0.00131	0.00693	CcSEcCtD
Adenosine—Tremor—Cisplatin—esophageal cancer	0.0013	0.00689	CcSEcCtD
Adenosine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00129	0.00684	CcSEcCtD
Adenosine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00129	0.00684	CcSEcCtD
Adenosine—Myocardial infarction—Capecitabine—esophageal cancer	0.00128	0.0068	CcSEcCtD
Adenosine—Convulsion—Cisplatin—esophageal cancer	0.0012	0.00637	CcSEcCtD
Adenosine—Mood swings—Methotrexate—esophageal cancer	0.0012	0.00635	CcSEcCtD
Adenosine—Bradycardia—Capecitabine—esophageal cancer	0.0012	0.00634	CcSEcCtD
Adenosine—Anxiety—Cisplatin—esophageal cancer	0.00118	0.00624	CcSEcCtD
Adenosine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00117	0.0062	CcSEcCtD
Adenosine—Discomfort—Cisplatin—esophageal cancer	0.00117	0.00619	CcSEcCtD
Adenosine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00113	0.006	CcSEcCtD
Adenosine—Tachycardia—Cisplatin—esophageal cancer	0.0011	0.00586	CcSEcCtD
Adenosine—Tinnitus—Capecitabine—esophageal cancer	0.00109	0.00581	CcSEcCtD
Adenosine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00109	0.0058	CcSEcCtD
Adenosine—Cardiac disorder—Capecitabine—esophageal cancer	0.00109	0.00578	CcSEcCtD
Adenosine—Flushing—Capecitabine—esophageal cancer	0.00109	0.00578	CcSEcCtD
Adenosine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00106	0.00561	CcSEcCtD
Adenosine—Hypotension—Cisplatin—esophageal cancer	0.00106	0.00561	CcSEcCtD
Adenosine—Arrhythmia—Capecitabine—esophageal cancer	0.00105	0.00556	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—esophageal cancer	0.00105	0.00555	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00103	0.00547	CcSEcCtD
Adenosine—Paraesthesia—Cisplatin—esophageal cancer	0.00102	0.00539	CcSEcCtD
Adenosine—Dyspnoea—Cisplatin—esophageal cancer	0.00101	0.00535	CcSEcCtD
Adenosine—Dysgeusia—Capecitabine—esophageal cancer	0.001	0.00531	CcSEcCtD
Adenosine—Back pain—Capecitabine—esophageal cancer	0.000989	0.00524	CcSEcCtD
Adenosine—Drowsiness—Methotrexate—esophageal cancer	0.000974	0.00517	CcSEcCtD
Adenosine—Pain—Cisplatin—esophageal cancer	0.000968	0.00513	CcSEcCtD
Adenosine—Vision blurred—Capecitabine—esophageal cancer	0.000963	0.00511	CcSEcCtD
Adenosine—Tremor—Capecitabine—esophageal cancer	0.000958	0.00508	CcSEcCtD
Adenosine—Sweating—Methotrexate—esophageal cancer	0.000933	0.00495	CcSEcCtD
Adenosine—Syncope—Capecitabine—esophageal cancer	0.000917	0.00486	CcSEcCtD
Adenosine—Palpitations—Capecitabine—esophageal cancer	0.000903	0.00479	CcSEcCtD
Adenosine—Loss of consciousness—Capecitabine—esophageal cancer	0.000898	0.00477	CcSEcCtD
Adenosine—Cough—Capecitabine—esophageal cancer	0.000892	0.00473	CcSEcCtD
Adenosine—Hypertension—Capecitabine—esophageal cancer	0.000882	0.00468	CcSEcCtD
Adenosine—Chest pain—Capecitabine—esophageal cancer	0.00087	0.00462	CcSEcCtD
Adenosine—Anxiety—Capecitabine—esophageal cancer	0.000867	0.0046	CcSEcCtD
Adenosine—Discomfort—Capecitabine—esophageal cancer	0.00086	0.00456	CcSEcCtD
Adenosine—Dry mouth—Capecitabine—esophageal cancer	0.000851	0.00451	CcSEcCtD
Adenosine—Hypersensitivity—Cisplatin—esophageal cancer	0.000834	0.00442	CcSEcCtD
Adenosine—Shock—Capecitabine—esophageal cancer	0.000821	0.00435	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—esophageal cancer	0.000815	0.00432	CcSEcCtD
Adenosine—Tachycardia—Capecitabine—esophageal cancer	0.000814	0.00432	CcSEcCtD
Adenosine—Asthenia—Cisplatin—esophageal cancer	0.000812	0.00431	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—esophageal cancer	0.000811	0.0043	CcSEcCtD
Adenosine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000806	0.00428	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000788	0.00418	CcSEcCtD
Adenosine—Hypotension—Capecitabine—esophageal cancer	0.000779	0.00414	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00076	0.00403	CcSEcCtD
Adenosine—Paraesthesia—Capecitabine—esophageal cancer	0.000749	0.00397	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—esophageal cancer	0.000745	0.00395	CcSEcCtD
Adenosine—Dyspnoea—Capecitabine—esophageal cancer	0.000744	0.00395	CcSEcCtD
Adenosine—Back pain—Methotrexate—esophageal cancer	0.000736	0.0039	CcSEcCtD
Adenosine—Vomiting—Cisplatin—esophageal cancer	0.000719	0.00382	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—esophageal cancer	0.000717	0.0038	CcSEcCtD
Adenosine—Rash—Cisplatin—esophageal cancer	0.000713	0.00379	CcSEcCtD
Adenosine—Pain—Capecitabine—esophageal cancer	0.000713	0.00378	CcSEcCtD
Adenosine—Dermatitis—Cisplatin—esophageal cancer	0.000713	0.00378	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—FBXW7—esophageal cancer	0.000682	0.00173	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALOX15—esophageal cancer	0.00068	0.00173	CbGpPWpGaD
Adenosine—Nausea—Cisplatin—esophageal cancer	0.000672	0.00357	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCB1—esophageal cancer	0.000671	0.0485	CrCbGaD
Adenosine—Cough—Methotrexate—esophageal cancer	0.000664	0.00352	CcSEcCtD
Adenosine—Urticaria—Capecitabine—esophageal cancer	0.000663	0.00352	CcSEcCtD
Adenosine—ADORA1—Signaling Pathways—GDI2—esophageal cancer	0.000661	0.00168	CbGpPWpGaD
Adenosine—Convulsion—Methotrexate—esophageal cancer	0.000659	0.0035	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.000654	0.00166	CbGpPWpGaD
Adenosine—ADK—Metabolism—TPI1—esophageal cancer	0.000649	0.00165	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTO1—esophageal cancer	0.000649	0.00165	CbGpPWpGaD
Adenosine—Chest pain—Methotrexate—esophageal cancer	0.000648	0.00344	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—ANXA1—esophageal cancer	0.000645	0.00164	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—NOS2—esophageal cancer	0.000641	0.00163	CbGpPWpGaD
Adenosine—Discomfort—Methotrexate—esophageal cancer	0.00064	0.0034	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.000636	0.00161	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—SST—esophageal cancer	0.000627	0.00159	CbGpPWpGaD
Adenosine—ADA—Metabolism—CA2—esophageal cancer	0.000626	0.00159	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALDOB—esophageal cancer	0.000622	0.00158	CbGpPWpGaD
Adenosine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000621	0.00329	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00062	0.00157	CbGpPWpGaD
Adenosine—Hypersensitivity—Capecitabine—esophageal cancer	0.000615	0.00326	CcSEcCtD
Adenosine—ADORA2A—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000613	0.00156	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—GHRL—esophageal cancer	0.000611	0.00155	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—GNG7—esophageal cancer	0.000608	0.00154	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKAP13—esophageal cancer	0.000601	0.00153	CbGpPWpGaD
Adenosine—Hyperhidrosis—Methotrexate—esophageal cancer	0.0006	0.00318	CcSEcCtD
Adenosine—ADK—Metabolism—GAPDH—esophageal cancer	0.000599	0.00152	CbGpPWpGaD
Adenosine—Asthenia—Capecitabine—esophageal cancer	0.000598	0.00318	CcSEcCtD
Adenosine—ADK—Metabolism—CRABP1—esophageal cancer	0.000593	0.00151	CbGpPWpGaD
Adenosine—ADA—Metabolism—PLCE1—esophageal cancer	0.000582	0.00148	CbGpPWpGaD
Adenosine—ADA—Metabolism—ADH7—esophageal cancer	0.000582	0.00148	CbGpPWpGaD
Adenosine—Hypotension—Methotrexate—esophageal cancer	0.00058	0.00308	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000566	0.003	CcSEcCtD
Adenosine—ADK—Metabolism—GNG7—esophageal cancer	0.000564	0.00143	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KMT2D—esophageal cancer	0.000562	0.00143	CbGpPWpGaD
Adenosine—Paraesthesia—Methotrexate—esophageal cancer	0.000558	0.00296	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—ADCYAP1—esophageal cancer	0.000556	0.00141	CbGpPWpGaD
Adenosine—Dyspnoea—Methotrexate—esophageal cancer	0.000554	0.00294	CcSEcCtD
Adenosine—Somnolence—Methotrexate—esophageal cancer	0.000552	0.00293	CcSEcCtD
Adenosine—Dizziness—Capecitabine—esophageal cancer	0.000552	0.00293	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—PDE4D—esophageal cancer	0.00055	0.0014	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKAP13—esophageal cancer	0.000546	0.00139	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL2—esophageal cancer	0.000535	0.00136	CbGpPWpGaD
Adenosine—Pain—Methotrexate—esophageal cancer	0.000531	0.00282	CcSEcCtD
Adenosine—Vomiting—Capecitabine—esophageal cancer	0.00053	0.00281	CcSEcCtD
Adenosine—ADK—Metabolism—ALDH2—esophageal cancer	0.000529	0.00134	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—EP300—esophageal cancer	0.000527	0.00134	CbGpPWpGaD
Adenosine—Rash—Capecitabine—esophageal cancer	0.000526	0.00279	CcSEcCtD
Adenosine—Dermatitis—Capecitabine—esophageal cancer	0.000525	0.00279	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—GNG7—esophageal cancer	0.000523	0.00133	CbGpPWpGaD
Adenosine—Headache—Capecitabine—esophageal cancer	0.000523	0.00277	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000511	0.0013	CbGpPWpGaD
Adenosine—ADA—Metabolism—ADH1B—esophageal cancer	0.00051	0.0013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GDI2—esophageal cancer	0.00051	0.00129	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTT1—esophageal cancer	0.000503	0.00128	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADCYAP1—esophageal cancer	0.000501	0.00127	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PDE4D—esophageal cancer	0.000499	0.00127	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—ANXA1—esophageal cancer	0.000498	0.00126	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP2A6—esophageal cancer	0.000497	0.00126	CbGpPWpGaD
Adenosine—Nausea—Capecitabine—esophageal cancer	0.000495	0.00263	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—NOS2—esophageal cancer	0.000495	0.00126	CbGpPWpGaD
Adenosine—Urticaria—Methotrexate—esophageal cancer	0.000493	0.00262	CcSEcCtD
Adenosine—ADA—Metabolism—TYMP—esophageal cancer	0.000488	0.00124	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—SST—esophageal cancer	0.000484	0.00123	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KMT2D—esophageal cancer	0.000478	0.00121	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—GNG7—esophageal cancer	0.000475	0.00121	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP26A1—esophageal cancer	0.000474	0.0012	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—GHRL—esophageal cancer	0.000472	0.0012	CbGpPWpGaD
Adenosine—ADK—Metabolism—ENO1—esophageal cancer	0.000471	0.0012	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS1—esophageal cancer	0.000471	0.0012	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000471	0.0012	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000468	0.00119	CbGpPWpGaD
Adenosine—ADK—Metabolism—PSME1—esophageal cancer	0.000464	0.00118	CbGpPWpGaD
Adenosine—ADK—Metabolism—PSME2—esophageal cancer	0.000464	0.00118	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKAP13—esophageal cancer	0.000464	0.00118	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALOX15—esophageal cancer	0.000462	0.00117	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL2—esophageal cancer	0.000461	0.00117	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—WWOX—esophageal cancer	0.000458	0.00116	CbGpPWpGaD
Adenosine—Hypersensitivity—Methotrexate—esophageal cancer	0.000457	0.00243	CcSEcCtD
Adenosine—Asthenia—Methotrexate—esophageal cancer	0.000446	0.00236	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—GNG7—esophageal cancer	0.000445	0.00113	CbGpPWpGaD
Adenosine—ADA—Metabolism—TPI1—esophageal cancer	0.000441	0.00112	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTO1—esophageal cancer	0.000441	0.00112	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FKBP1A—esophageal cancer	0.000435	0.00111	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—ANXA1—esophageal cancer	0.000428	0.00109	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—WIF1—esophageal cancer	0.000426	0.00108	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000426	0.00108	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PDE4D—esophageal cancer	0.000425	0.00108	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALDOB—esophageal cancer	0.000423	0.00107	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL2—esophageal cancer	0.000419	0.00106	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—SST—esophageal cancer	0.000417	0.00106	CbGpPWpGaD
Adenosine—Dizziness—Methotrexate—esophageal cancer	0.000411	0.00218	CcSEcCtD
Adenosine—ADA—Metabolism—GAPDH—esophageal cancer	0.000407	0.00103	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—GHRL—esophageal cancer	0.000406	0.00103	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—GNG7—esophageal cancer	0.000404	0.00103	CbGpPWpGaD
Adenosine—ADA—Metabolism—CRABP1—esophageal cancer	0.000403	0.00102	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP1B1—esophageal cancer	0.000401	0.00102	CbGpPWpGaD
Adenosine—Vomiting—Methotrexate—esophageal cancer	0.000395	0.00209	CcSEcCtD
Adenosine—ADORA2A—GPCR downstream signaling—AKAP13—esophageal cancer	0.000395	0.001	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CSNK1A1—esophageal cancer	0.000393	0.000997	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—EP300—esophageal cancer	0.000392	0.000995	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000392	0.000995	CbGpPWpGaD
Adenosine—Rash—Methotrexate—esophageal cancer	0.000392	0.00208	CcSEcCtD
Adenosine—Dermatitis—Methotrexate—esophageal cancer	0.000391	0.00208	CcSEcCtD
Adenosine—ADORA1—Signaling Pathways—WWOX—esophageal cancer	0.000389	0.000988	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—ANXA1—esophageal cancer	0.000389	0.000988	CbGpPWpGaD
Adenosine—Headache—Methotrexate—esophageal cancer	0.000389	0.00206	CcSEcCtD
Adenosine—ADA—Metabolism—GNG7—esophageal cancer	0.000384	0.000974	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—SST—esophageal cancer	0.000378	0.000961	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TP53—esophageal cancer	0.000377	0.000958	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP19A1—esophageal cancer	0.000377	0.000956	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FKBP1A—esophageal cancer	0.00037	0.00094	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—GHRL—esophageal cancer	0.000369	0.000936	CbGpPWpGaD
Adenosine—Nausea—Methotrexate—esophageal cancer	0.000369	0.00196	CcSEcCtD
Adenosine—ADORA2A—Signaling Pathways—KMT2D—esophageal cancer	0.000369	0.000936	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PFN1—esophageal cancer	0.000367	0.000933	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—esophageal cancer	0.000365	0.000927	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000364	0.000925	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—WIF1—esophageal cancer	0.000362	0.000919	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PDE4D—esophageal cancer	0.000361	0.000917	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALDH2—esophageal cancer	0.000359	0.000912	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKAP13—esophageal cancer	0.000358	0.00091	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL2—esophageal cancer	0.000356	0.000903	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—SST—esophageal cancer	0.000354	0.0009	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—GHRL—esophageal cancer	0.000345	0.000877	CbGpPWpGaD
Adenosine—ADK—Metabolism—HMOX1—esophageal cancer	0.000344	0.000873	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GNG7—esophageal cancer	0.000343	0.000872	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTT1—esophageal cancer	0.000342	0.000868	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP2A6—esophageal cancer	0.000338	0.000858	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000334	0.000848	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—ANXA1—esophageal cancer	0.000331	0.00084	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ELMO1—esophageal cancer	0.00033	0.000838	CbGpPWpGaD
Adenosine—ADK—Metabolism—ABCB1—esophageal cancer	0.00033	0.000838	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADCYAP1—esophageal cancer	0.000329	0.000834	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PDE4D—esophageal cancer	0.000328	0.000832	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKAP13—esophageal cancer	0.000323	0.000819	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—SST—esophageal cancer	0.000322	0.000817	CbGpPWpGaD
Adenosine—ADA—Metabolism—ENO1—esophageal cancer	0.00032	0.000813	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS1—esophageal cancer	0.00032	0.000813	CbGpPWpGaD
Adenosine—ADA—Metabolism—PSME2—esophageal cancer	0.000316	0.000801	CbGpPWpGaD
Adenosine—ADA—Metabolism—PSME1—esophageal cancer	0.000316	0.000801	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—GHRL—esophageal cancer	0.000314	0.000796	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PFN1—esophageal cancer	0.000312	0.000793	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—esophageal cancer	0.000312	0.000792	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GNG7—esophageal cancer	0.000312	0.000792	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—EP300—esophageal cancer	0.000303	0.000769	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000303	0.000768	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—WWOX—esophageal cancer	0.000301	0.000763	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000298	0.000756	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PDE4D—esophageal cancer	0.000295	0.000749	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FKBP1A—esophageal cancer	0.000286	0.000726	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000281	0.000714	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ERBB2—esophageal cancer	0.000281	0.000713	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GNG7—esophageal cancer	0.000281	0.000712	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ELMO1—esophageal cancer	0.000281	0.000712	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—esophageal cancer	0.000281	0.000712	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—WIF1—esophageal cancer	0.000279	0.000709	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL2—esophageal cancer	0.000275	0.000697	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKAP13—esophageal cancer	0.000274	0.000696	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—SST—esophageal cancer	0.000274	0.000695	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP1B1—esophageal cancer	0.000272	0.000692	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GHRL—esophageal cancer	0.000267	0.000677	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—XIAP—esophageal cancer	0.000263	0.000668	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000258	0.000655	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP19A1—esophageal cancer	0.000256	0.00065	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ANXA1—esophageal cancer	0.000255	0.000648	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000253	0.000643	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—esophageal cancer	0.000253	0.000642	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PDE4D—esophageal cancer	0.000251	0.000637	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000249	0.000631	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—SST—esophageal cancer	0.000248	0.000631	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL2—esophageal cancer	0.000247	0.000628	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000242	0.000615	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PFN1—esophageal cancer	0.000241	0.000612	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CDKN1A—esophageal cancer	0.00024	0.000609	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GNG7—esophageal cancer	0.000239	0.000606	CbGpPWpGaD
Adenosine—ADA—Metabolism—HMOX1—esophageal cancer	0.000234	0.000593	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PSME1—esophageal cancer	0.000231	0.000586	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PSME2—esophageal cancer	0.000231	0.000586	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ANXA1—esophageal cancer	0.00023	0.000583	CbGpPWpGaD
Adenosine—ADA—Metabolism—ABCB1—esophageal cancer	0.000224	0.000569	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SST—esophageal cancer	0.000224	0.000568	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—XIAP—esophageal cancer	0.000224	0.000568	CbGpPWpGaD
Adenosine—ADK—Metabolism—CREBBP—esophageal cancer	0.000221	0.00056	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—esophageal cancer	0.00022	0.000557	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000218	0.000553	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GHRL—esophageal cancer	0.000218	0.000553	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ELMO1—esophageal cancer	0.000217	0.00055	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—esophageal cancer	0.000217	0.00055	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000214	0.000544	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKAP13—esophageal cancer	0.000212	0.000538	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNA1—esophageal cancer	0.000211	0.000537	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL2—esophageal cancer	0.00021	0.000534	CbGpPWpGaD
Adenosine—ADK—Metabolism—NOS3—esophageal cancer	0.000197	0.000501	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PSME2—esophageal cancer	0.000196	0.000498	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PSME1—esophageal cancer	0.000196	0.000498	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000195	0.000496	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ANXA1—esophageal cancer	0.000195	0.000496	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000195	0.000496	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—esophageal cancer	0.000195	0.000494	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000194	0.000492	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SST—esophageal cancer	0.00019	0.000483	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GHRL—esophageal cancer	0.000185	0.00047	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH3—esophageal cancer	0.000185	0.00047	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GNG7—esophageal cancer	0.000184	0.000468	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FBXW7—esophageal cancer	0.000182	0.000463	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—esophageal cancer	0.000181	0.000458	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000173	0.00044	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—XIAP—esophageal cancer	0.000173	0.000438	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—esophageal cancer	0.000169	0.000429	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH2—esophageal cancer	0.000166	0.000422	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000164	0.000417	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000163	0.000414	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL2—esophageal cancer	0.000162	0.000412	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PSME1—esophageal cancer	0.000152	0.000385	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PSME2—esophageal cancer	0.000152	0.000385	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000151	0.000383	CbGpPWpGaD
Adenosine—ADK—Metabolism—EP300—esophageal cancer	0.00015	0.000381	CbGpPWpGaD
Adenosine—ADA—Metabolism—CREBBP—esophageal cancer	0.00015	0.000381	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFBR2—esophageal cancer	0.000147	0.000374	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SST—esophageal cancer	0.000147	0.000373	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000143	0.000363	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GHRL—esophageal cancer	0.000143	0.000363	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FBXW7—esophageal cancer	0.000141	0.000357	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SMAD4—esophageal cancer	0.00014	0.000354	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIF1A—esophageal cancer	0.000134	0.000341	CbGpPWpGaD
Adenosine—ADA—Metabolism—NOS3—esophageal cancer	0.000134	0.000341	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KDR—esophageal cancer	0.000128	0.000326	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000128	0.000326	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—esophageal cancer	0.000123	0.000312	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000121	0.000307	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIF1A—esophageal cancer	0.000114	0.00029	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000114	0.000289	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—esophageal cancer	0.000111	0.000282	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CREBBP—esophageal cancer	0.00011	0.000278	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KDR—esophageal cancer	0.000109	0.000277	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—esophageal cancer	0.000108	0.000274	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMAD4—esophageal cancer	0.000108	0.000273	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000103	0.000261	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH1—esophageal cancer	0.000103	0.000261	CbGpPWpGaD
Adenosine—ADA—Metabolism—EP300—esophageal cancer	0.000102	0.000259	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOS3—esophageal cancer	9.82e-05	0.000249	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—esophageal cancer	9.35e-05	0.000237	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CREBBP—esophageal cancer	9.33e-05	0.000237	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—esophageal cancer	9.19e-05	0.000233	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—esophageal cancer	9.16e-05	0.000233	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIF1A—esophageal cancer	8.82e-05	0.000224	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—esophageal cancer	8.76e-05	0.000222	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KDR—esophageal cancer	8.43e-05	0.000214	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOS3—esophageal cancer	8.35e-05	0.000212	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—esophageal cancer	8.12e-05	0.000206	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—esophageal cancer	7.95e-05	0.000202	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH1—esophageal cancer	7.94e-05	0.000202	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1A—esophageal cancer	7.85e-05	0.000199	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—esophageal cancer	7.81e-05	0.000198	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—esophageal cancer	7.55e-05	0.000192	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EP300—esophageal cancer	7.47e-05	0.00019	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CREBBP—esophageal cancer	7.2e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—esophageal cancer	7.08e-05	0.00018	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—esophageal cancer	6.9e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.76e-05	0.000172	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1A—esophageal cancer	6.68e-05	0.000169	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—esophageal cancer	6.51e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOS3—esophageal cancer	6.45e-05	0.000164	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—esophageal cancer	6.37e-05	0.000162	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EP300—esophageal cancer	6.35e-05	0.000161	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—esophageal cancer	6.14e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—esophageal cancer	6.03e-05	0.000153	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—esophageal cancer	5.53e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—esophageal cancer	5.53e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—esophageal cancer	5.41e-05	0.000137	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—esophageal cancer	5.35e-05	0.000136	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—esophageal cancer	5.33e-05	0.000135	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1A—esophageal cancer	5.15e-05	0.000131	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EP300—esophageal cancer	4.9e-05	0.000124	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—esophageal cancer	4.7e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—esophageal cancer	4.55e-05	0.000115	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—esophageal cancer	4.27e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—esophageal cancer	4.18e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—esophageal cancer	3.63e-05	9.21e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—esophageal cancer	3.51e-05	8.91e-05	CbGpPWpGaD
